The level of anti-topoisomerase I antibodies highly correlates with metacarpophalangeal and proximal interphalangeal joints flexion contractures in patients with systemic sclerosis

被引:0
|
作者
Radic, M. [1 ]
Kaliterna, D. Martinovic [1 ]
Ljutic, D. [1 ]
机构
[1] Clin Hosp Split, Dept Internal Med, Split, Croatia
关键词
systemic sclerosis; anti-topoisomerase I antibody; contracture;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background It is found that an antibody directed against DNA topoisomerase I (anti-topo I abs) is detected almost exclusively in systemic sclerosis (SSc). These antibodies are predictors of pulmonary fibrosis and peripheral vascular disease. Objective Metacarpophalangeal (MCP) and proximal interphalangeal (PIP) joints flexion contractures are assessed as markers of active SSc. The aim of this study was to find out is there any relationship between anti-topo I abs and MCP and PIP joints flexion contractures. Methods Twenty-eight patients with active disease who fulfilled the American College of Rheumatology criteria for SSc were included in this study. Twenty eight healthy control subjects were also investigated. Clinical and radiological assessments of the hands were carried out. The flexion ranges in the 8 finger joints by goniometric measurement were obtained. Anti-topo I abs with an enzyme linked immunosorbent assay (ELISA) were measured. Results MCP and PIP joints flexion contractures and the levels of anti-topo I abs were significantly higher in patients with systemic sclerosis than in healthy control. The anti-topo I abs were found in 16 of 28 patients with systemic sclerosis. Sixteen of 28 patients with active disease had MPC and proximal PIP joints flexion contractures. In 16 SSc patients with anti-topo I abs, 13 had metacarpophalangeal and proximal interphalangeal joints flexion contractures. In only 3 patients of 16 with the flexion contractures the levels of anti-topo I abs were negative. The patients with MPC and PIP joints flexion contractures had higher mean value of anti-topo I abs titers (53.718 +/- 50.977 vs 8.127 +/- 8.915, P < 0.0001) than did those with no contractures. Furthermore, the titers of anti-topo isomerase I antibody positively correlated with the flexion contractures (r = 0.4252, P = 0.0241). Radiologically, joint space narrowing and flexion contractures of the fingers were seen significantly more frequently in the SSc patients with anti-topo I abs (P < 0.05). Conclusion Serum level of anti-topoisomerase I antibodies is in direct relationship with MPC and PIP joints flexion contractures.
引用
收藏
页码:407 / 412
页数:6
相关论文
共 50 条
  • [31] DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients
    Hénault, J
    Robitaille, G
    Senécal, JL
    Raymond, Y
    ARTHRITIS AND RHEUMATISM, 2006, 54 (03): : 963 - 973
  • [32] Anti-RNA polymerase antibodies in systemic sclerosis (SSc): Association with anti-topoisomerase I antibodies and identification of autoreactive subunits of RNA polymerase II
    Harvey, GR
    Rands, AL
    McHugh, NJ
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1996, 105 (03): : 468 - 474
  • [33] Ability of anti-centromere and anti-topoisomerase antibodies to distinguish subsets of skin involvement in systemic sclerosis.
    Hudson, Marie
    Taillefer, Suzanne
    Steele, Russell
    Fritzler, Marvin
    Baron, Murray
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S482 - S482
  • [34] Levels of anti-topoisomerase I antibody correlated with short onset of cardiopulmonary involvement in Thai systemic sclerosis patients
    Mulalin, Kamonwan
    Mahakkanukrauh, Ajanee
    Suwannaroj, Siraphop
    Pongkulkiat, Patnarin
    Onchan, Tippawan
    Kasa, Sawinee
    Foocharoen, Chingching
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [35] Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody
    Komura, K.
    Yanaba, K.
    Ogawa, F.
    Shimizu, K.
    Takehara, K.
    Sato, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2008, 33 (03) : 329 - 332
  • [36] DNA topoisomerase I binding to fibroblasts induces monocyte adhesion and activation in the presence of anti-topoisomerase I autoantibodies from systemic sclerosis patients.
    Senécal, JL
    Hénault, J
    Raymond, Y
    JOURNAL OF RHEUMATOLOGY, 2006, 33 (02) : 382 - 382
  • [37] Patients with diffuse systemic sclerosis with or without anti-topoisomerase I antibodies recognize the same 85 kDa protein band in endothelial cell extracts.
    de la Pena-Lefebvre, PG
    Chanseaud, Y
    Guillevin, L
    Allanore, Y
    Kahan, A
    Meyer, O
    Boissier, MC
    Mouthon, L
    ARTHRITIS AND RHEUMATISM, 2001, 44 (09): : S195 - S195
  • [38] Re-emergence of anti-topoisomerase I antibody with exacerbated development of skin sclerosis in a patient with systemic sclerosis
    Hamaguchi, Yasuhito
    Fujimoto, Manabu
    Hasegawa, Minoru
    Matsushita, Takashi
    Takehara, Kazuhiko
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2010, 62 (01) : 142 - 144
  • [39] Anti-topoisomerase 1 Antibody Level Changes after B Cell Depletion Therapy in Systemic Sclerosis
    L. P. Ananyeva
    L. A. Garzanova
    O. A. Koneva
    M. N. Starovoytova
    O. V. Desinova
    O. B. Ovsyannikova
    R. U. Shayakhmetova
    M. V. Cherkasova
    A. P. Aleksankin
    E. L. Nasonov
    Doklady Biochemistry and Biophysics, 2023, 511 : 212 - 218
  • [40] Immunoblotting on Hep2 cell protein extracts increases the detection of anti-topoisomerase 1 antibodies in patients with systemic sclerosis
    Tamby, MC
    Servettaz, A
    Chanseaud, Y
    de la Peña-Lefebvre, PG
    Reinbolt, J
    Guillevin, L
    Mouthon, L
    ARTHRITIS AND RHEUMATISM, 2004, 50 (09): : S633 - S633